Thiazolidine compounds as calcium sensing receptor modulators

Details Thiazolidine compounds as calcium sensing receptor modulators Thiazolidine compounds as calcium sensing receptor modulators

2007-04-17

2007-04-17

Stockton, Laura L. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S146000

Reexamination Certificate

active

10775742

ABSTRACT:
The present invention relates to modulators of the calcium sensing receptor having the formula IwhereinAr1, X, J, R1, R2, R3, R7, R8and Q are as defined herein.

REFERENCES:
patent: 4411890 (1983-10-01), Momany
patent: 5688938 (1997-11-01), Brown et al.
patent: 5763569 (1998-06-01), Brown et al.
patent: 6022894 (2000-02-01), Del Mar et al.
patent: 6031003 (2000-02-01), Nemeth et al.
patent: 6211244 (2001-04-01), Van Wagenen et al.
patent: 6673821 (2004-01-01), Wang et al.
patent: 0342613 (1992-11-01), None
patent: 0449011 (1997-10-01), None
patent: WO 89/07110 (1989-08-01), None
patent: WO 89/07111 (1989-08-01), None
patent: WO 93/04081 (1993-03-01), None
patent: WO 94/18959 (1994-09-01), None
patent: WO 97/37967 (1997-10-01), None
patent: WO 98/45255 (1998-10-01), None
patent: WO 99/51241 (1999-10-01), None
patent: WO 99/51569 (1999-10-01), None
patent: WO 00/45816 (2000-08-01), None
patent: WO 01/08673 (2001-02-01), None
Arndt, D., “Mangan-Verbindungen als Oxidationsmittel in der organischen Chemie”, Methoden der Organischen Chemie (Houben-Weyl), Fourth Edition, vol. 4, Part 1b, Georg Thieme Verlag, Stuttgart, publ., Müller, E., ed., pp. 466-672 (1975).
Betts, M.J. et al., “‘Hidden’ axial chirality as a stereodirecting element in reactions involving enol(ate) intermediates. Part 2. Cyclisation reactions of methyl (4R)-3-(2-diazo-3-oxobutanoyl)-1, 1-dioxo-1λ6, 3-(and 1-oxo-1λ4, 3-) thiazolidine-4-carboxylates”, J. Chem. Soc., Perkin Trans. 1, pp. 1067-1072 (1999).
Bundgaard, H., Chapter 5: “Design and Application of Prodrugs”, A Textbook of Drug Design and Development, Harwood Academic Publishers, publ., Krogsgaard-Larsen, P. et al., eds., pp. 113-191 (1991).
Bundgaard, H., ed., Design of Prodrugs, Elsevier Science Publishers B.V., publ. (1985) (table of contents).
Cagniant, P. et al., “No. 50. Sur la synthése de quelques amines arylaliphatiques dérivées du β-méthyl-naphtaléne”, Bull. Soc. Chim. Fr., pp. 349-353 (1943).
Edwards, J.P. et al., “Nonsteroidal Androgen Receptor Agonists Based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one”, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1003-1008 (1999).
Florvall, L. et al., “Selective Monoamine Oxidase Inhibitors. 3. Cyclic Compounds Related to 4-Aminophenethylamine. Preparation and Neuron-Selective Action of Some 5-(2-Aminoethyl)-2,3-dihydroindoles”, J. Med. Chem., vol. 29, No. 8, pp. 1406-1412 (1986).
Gowen, M. et al., “Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats”, The Journal of Clinical Investigation, vol. 105, No. 11, pp. 1595-1604 (2000).
Greene, T.W. et al., Protecting Groups in Organic Synthesis, Third Edition, John Wiley & Sons, Inc., publ. (1999) (table of contents).
Greenstein, J.P. et al., Chemistry of the Amino Acids, vol. 3, Robert E. Krieger Publishing Company, Inc., publ., pp. v-xiii (table of contents) (1984).
Hamann, L.G. et al., “Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6-(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071)”, J. Med. Chem., vol. 42, pp. 210-212 (1999).
Lee, D.G., Chapter 11: “Phase Transfer Assisted Permanganate Oxidations”, Oxidation in Organic Chemistry, Part D, Academic Press, publ., Trahanovsky, W.S., ed., pp. 147-204 (1982).
Moed, H.D. et al., “Synthesis of β-phenyl-ethylamine Derivaties. III) Bronchodilators”, Recl. Trav. Chim. Pays-Bas, vol. 74, pp. 919-936 (1955).
Neer, R.M. et al., “Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis”, The New England Journal of Medicine, vol. 344, No. 19, pp. 1434-1441 (2001).
Nichols, D.E. et al., “Effects of Certain Hallucinogenic Amphetamine Analogues on the Release of [3H]Serotonin from Rat Brain Synaptosomes”, J. Med. Chem., vol. 25, No. 5, pp. 530-535 (1982).
Norris, R.K. et al., “Kinetics and Stereochemistry of Elimination of Nitrous Acid from 1-p-Nitrophenyl-2-nitroethyl Derivatives”, Aust. J. Chem., vol. 39, pp. 281-294 (1986).
Stewart, R., Chapter 1: “Oxidation by Permanganate”, Oxidation in Organic Chemistry, Part A, Academic Press, publ., Wiberg, K.B., ed., pp. 1-68 (1965).
Wermuth, C.G. et al., Chapter 31: “Designing Prodrugs and Bioprecursors I: Carrier Prodrugs”, The Practice of Medicinal Chemistry, Academic Press, publ., Wermuth, C.G., ed., pp. 671-696 (1996).
Whitfield, J.F. et al., “Parathyroid Hormone, Its Fragments and Their Analogs for the Treatment of Osteoporosis”, Treat. Endocrinol., vol. 1, No. 3, pp. 175-190 (2002).
Brown, E.M. et al., “Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid”, Nature, vol. 366, pp. 575-580 (1993).
Hudlicky, M., Oxidations in Organic Chemistry: ACS Monograph 186, American Chemical Society, publ., pp. ix-xiii (table of contents) (1990).
Larock, R.C., Comprehensive Organic Transformations: A Guide to Functional Group Preparations, VCH Publishers, Inc., publ., pp. xiii-xxviii (table of contents) (1989).
Zaragoza, F. et al., “(Cyanomethyl)trialkylphosphonium Iodides: Efficient Reagents for the Intermolecular Alkylation of Amines with Alcohols in Solution and on Solid Phase”, J. Org. Chem., vol. 66, No. 7, pp. 2518-2521 (2001).

Affiliated with

Also associated with

Rating

Thiazolidine compounds as calcium sensing receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolidine compounds as calcium sensing receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine compounds as calcium sensing receptor modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3787748